Search Results for "opioids"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for opioids. Results 121 to 130 of 180 total matches.
Ketorolac Tromethamine
The Medical Letter on Drugs and Therapeutics • Aug 24, 1990 (Issue 825)
less postoperative constipation and drowsiness than opioids. It does not have the depen- dence ...
Ketorolac (kee'; toe role ak) tromethamine (Toradol), manufactured by Syntex but also marketed by Roche, is the first parenteral nonsteroidal anti-inflammatory drug (NSAID) to become available for analgesic use in the USA. Parenteral indomethacin (Indocin I.V.) has been marketed here since 1985, but only for treatment of patent ductus arteriosus in newborn infants. Other parenteral NSAIDs are available in other parts of the world, but low potency, poor aqueous solubility, and substantial tissue irritation on injection have limited their usefulness. Ketorolac has been approved by the US ...
Tests for Drugs of Abuse
The Medical Letter on Drugs and Therapeutics • Aug 19, 2002 (Issue 1137)
structurally dissimilar opioids such as oxycodone (Oxycontin, and others) or meperidine
(Demerol, and others ...
Testing for drug use has become increasingly common, not only in health care, but also in drug rehabilitation, in the military, at the workplace, after accidents and in the criminal justice system. Performance-enhancing drugs such as anabolic steroids, growth hormone (Genotropin, and others) and erythropoietin (Procrit, Epogen) are not discussed here.
CYP3A and Drug Interactions
The Medical Letter on Drugs and Therapeutics • Jul 04, 2005 (Issue 1212)
), troleandomycin (TAO)
Opioids: alfentanyl (Alfenta*), fentanyl (Sublimaze*), sufentanil
(Sufenta*)
Steroids ...
Serious adverse interactions between drugs continue to be reported. Many of these are due to inhibition or induction of cytochrome P450 (CYP) enzymes, particularly CYP3A4. CYP3A is thought to be involved in the metabolism of more than 50 percent of currently prescribed drugs.2 CYP3A4, which is more abundantly expressed than CYP3A5, accounts for most CYP3A activity in vivo.
Intranasal Diazepam (Valtoco) and Midazolam (Nayzilam) for Seizure Clusters
The Medical Letter on Drugs and Therapeutics • Apr 20, 2020 (Issue 1596)
inhibitors.6
Concurrent administration of benzodiazepines and
opioids can cause profound sedation ...
The FDA has approved nasal spray formulations of
the benzodiazepines diazepam (Valtoco — Neurelis)
and midazolam (Nayzilam — UCB) for acute treatment
of intermittent episodes of frequent seizure activity
(seizure clusters). Diazepam rectal gel (Diastat, Diastat
AcuDial, and generics) has been used for this indication
for many years.
Gamma Hydroxy Butyrate Poisoning
The Medical Letter on Drugs and Therapeutics • Jan 25, 1991 (Issue 836)
neuroactive, increasing dopamine
levels in the brain and acting on the endogenous opioid system (M Mamelak ...
Gamma hydroxy butyrate (GHB) sold in health food stores has recently caused outbreaks of gastrointestinal illness, central-nervous-system (CNS) depression, and seizures.
Drugs and Devices for Weight Management
The Medical Letter on Drugs and Therapeutics • Aug 04, 2025 (Issue 1734)
-69% 209.00
Qsymia (Vivus) 15/92 mg ER caps PO qAM12
Opioid Antagonist/Antidepressant Combination ...
Overweight is generally defined as a body mass
index (BMI) between 25 and 29.9 kg/m2 in adults. A
BMI ≥30 is considered obese (criteria differ slightly in
Asian patients). In patients with an elevated BMI, a
5-10% reduction in weight has been associated with
a reduction in the risk of developing type 2 diabetes,
hypertension, and dyslipidemia. Diet, exercise, and
behavior modification are the traditional methods
for losing weight, but they are often inadequate; the
American College of Cardiology no longer recommends
that all patients try lifestyle modification alone before
adding...
Med Lett Drugs Ther. 2025 Aug 4;67(1734):121-8 doi:10.58347/tml.2025.1734a | Show Introduction Hide Introduction
In Brief: Palladone Withdrawn
The Medical Letter on Drugs and Therapeutics • Aug 01, 2005 (Issue 1214)
Oramorph opioids MS Contin Morphine Kadian Hydromorphone ...
The Medical Letter review of Palladone (hydromorphone HCl) extended-release capsules (March 14, 2005) warned that a lethal dose could be released if the new formulation was taken with alcohol. Because of that risk, the FDA asked the manufacturer (Purdue) to withdraw the drug from the market (FDA News. July 13, 2005; FDC Reports – “The Pink Sheet” July 18, 2005; 67:3).
Table: Some Drug Interactions with Drugs for IBD (online only)
The Medical Letter on Drugs and Therapeutics • Jul 10, 2023 (Issue 1680)
opioids) or noradrenergic drugs with ozanimod could result in hypertensive crisis and is not recommended ...
View the Table: Some Drug Interactions with Drugs for IBD
Med Lett Drugs Ther. 2023 Jul 10;65(1680):e114 doi:10.58347/tml.2023.1680c | Show Introduction Hide Introduction
Gabapentin (Neurontin) for Chronic Pain
The Medical Letter on Drugs and Therapeutics • Apr 12, 2004 (Issue 1180)
not respond as well as other types of pain to standard
doses of opioids. Anticonvulsants are often used ...
Gabapentin (Neurontin - Pfizer), which has been available in the US since 1994, is approved by the FDA only for treatment of partial epilepsy and postherpetic neuralgia, but is widely used off-label for a number of other indications, especially neuropathic pain syndromes. According to one report, among Medicaid recipients in Florida receiving gabapentin, 71% of prescriptions were for chronic pain and 8% for seizures and neuralgia ("The Pink Sheet" February 2, 2004; 66:30).
Uterine Artery Embolization for Fibroids
The Medical Letter on Drugs and Therapeutics • Apr 11, 2005 (Issue 1206)
and administration of parenteral opioids.
UAE is generally not recommended for women who
have not completed ...
Uterine artery embolization (UAE) is an increasingly used alternative to surgery for treatment of uterine fibroids.